Vav-2 is a signaling molecule downstream of BCR, which, together with Vav-1, enables B cells to surmount a signaling threshold of activation required for B cell development and function.

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...